HilleVax, Inc. (HLVX)
NASDAQ: HLVX · Real-Time Price · USD
1.471
-0.119 (-7.51%)
Mar 31, 2025, 1:37 PM EDT - Market open
HilleVax Market Cap
HilleVax has a market cap or net worth of $72.39 million as of March 31, 2025. Its market cap has decreased by -91.35% in one year.
Market Cap
72.39M
Enterprise Value
-68.65M
1-Year Change
-91.35%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since the IPO on April 29, 2022, HilleVax's market cap has decreased from $538.26M to $72.39M, a decrease of -86.55%. That is a compound annual growth rate of -49.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 78.26M | -21.61% |
| Dec 31, 2024 | 99.85M | -86.63% |
| Dec 29, 2023 | 746.58M | 25.20% |
| Dec 30, 2022 | 596.32M | 10.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |